Abstract:Background Current approaches fail to separate patients at high versus low risk for ventricular arrhythmias owing to overreliance on a snapshot left ventricular ejection fraction measure. We used statistical machine learning to identify important cardiac imaging and time‐varying risk predictors. Methods and Results Three hundred eighty‐two cardiomyopathy patients (left ventricular ejection fraction ≤35%) underwent cardiac magnetic resonance before primary prevention implantable cardioverter defibrillator insertion. The primary end point was appropriate implantable cardioverter defibrillator discharge or sudden death. Patient characteristics; serum biomarkers of inflammation, neurohormonal status, and injury; and cardiac magnetic resonance‐measured left ventricle and left atrial indices and myocardial scar burden were assessed at baseline. Time‐varying covariates comprised interval heart failure hospitalizations and left ventricular ejection fractions. A random forest statistical method for survival, longitudinal, and multivariable outcomes incorporating baseline and time‐varying variables was compared with (1) Seattle Heart Failure model scores and (2) random forest survival and Cox regression models incorporating baseline characteristics with and without imaging variables. Age averaged 57±13 years with 28% women, 66% white, 51% ischemic, and follow‐up time of 5.9±2.3 years. The primary end point (n=75) occurred at 3.3±2.4 years. Random forest statistical method for survival, longitudinal, and multivariable outcomes with baseline and time‐varying predictors had the highest area under the receiver operating curve, median 0.88 (95% CI, 0.75‐0.96). Top predictors comprised heart failure hospitalization, left ventricle scar, left ventricle and left atrial volumes, left atrial function, and interleukin‐6 level; heart failure accounted for 67% of the variation explained by the prediction, imaging 27%, and interleukin‐6 2%. Serial left ventricular ejection fraction was not a significant predictor. Conclusions Hospitalization for heart failure and baseline cardiac metrics substantially improve ventricular arrhythmic risk prediction. Nonstandard Abbreviations and Acronyms LGE late gadolinium enhancement RF‐SLAM random forest survival, longitudinal and multivariate outcomes SCD sudden cardiac death SI signal intensity Clinical Perspective What Is New? In primary prevention implanted cardioverter defibrillator (ICD) recipients, an interim hospitalization for heart failure identified a group at high risk for subsequent ventricular arrhythmia defined as an appropriate ICD shock. Among ICD recipients without heart failure hospitalizations, baseline cardiac magnetic resonance imaging metrics (specifically, left ventricle heterogeneous gray and total scar, left ventricle and left atrial volumes, and left atrial total emptying fraction) as well as serum interleukin‐6 levels were the strongest predictors of subsequent appropriate ICD shock; serial left ventricle ejection fraction did not provide additional prognostic value for the arrhythmic outcome. Machine learning statistical methods may improve risk score development by accounting for complex and dynamic interactions among risk variables and temporally varying risk. What Are the Clinical Implications? The combination of clinical heart failure course, baseline cardiac magnetic resonance imaging metrics, and levels of the inflammatory biomarker interleukin‐6 can most accurately stratify subsequent high versus low ventricular arrhythmic risk and may be useful for decision‐making as primary prevention ICD recipients approach elective generator change. Identifying patients most at risk for ventricular arrhythmias and sudden cardiac death (SCD) remains a clinical challenge. 1 Current guidelines directing the use of primary prevention implanted cardioverter defibrillator (ICDs) rely on a reduced left ventricular ejection fraction (LVEF), which has low predictive efficiency. 1 Estimated annualized rates of appropriat -Abstract Truncated-

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy.

MRI Assessment of Myocardial Deformation for Risk Stratification of Major Arrhythmic Events in Patients With Non‐Ischemic Cardiomyopathy Eligible for Primary Prevention Implantable Cardioverter Defibrillators

Prophylactic ICD Survival Benefit Prediction: Review and Comparison between Main Scores

Abstract 13047: Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators (Icds)

Multivariate Logistic Regression Analysis of Appropriate Therapy of Implantable Cardioverter Defibrillator for Primary Prevention

Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35

Prognostic Value of Different Thresholds for Myocardial Scar Quantification on Cardiac MRI Late Gadolinium Enhancement Images in Patients Receiving Implantable Cardioverter Defibrillators

Looking for appropriate criterias for SCD prevention: prognostic role of MRI in patients with nonischemic ventricular arrhythmias

Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts

Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring

Will Imaging Assist in the Selection of Patients With Heart Failure for an ICD?

Combining noninvasive risk stratification parameters improves the prediction of mortality and appropriate ICD shocks

Abstract 11960: Right Ventricular Diameter in Risk Stratification of Sudden Cardiac Death

Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death

Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias

Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy

Risk of Appropriate Implantable Cardioverter-Defibrillator Therapies and Sudden Cardiac Death in Patients With Heart Failure With Improved Left Ventricular Ejection Fraction

Left atrial booster pump function is an independent predictor of subsequent life-threatening ventricular arrhythmias in non-ischaemic cardiomyopathy

Machine Learning-Based Clustering Using a 12-Lead Electrocardiogram in Patients With a Implantable Cardioverter Defibrillator to Identify Future Ventricular Arrhythmia

Risk stratification for ventricular tachyarrhythmia in patients with nonischemic cardiomyopathy

Sudden Cardiac Death in Ischaemic Cardiomyopathy and the Primary Prevention ICD: Time for a More a Personalised Approach?